Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
for candidates interested in acquiring experience of research in a world-class academic unit (see http://www.wrh.ox.ac.uk). The post supports a Phase III programme of work aimed at testing and validating
-
Colorectal Cancer - Stratification of Therapies through Adaptive Responses (CRC-STARS) programme, developing and applying cutting-edge mathematical methods to spatial transcriptomics imaging data in order to
-
/workforce-and-learning-research-group ). The Compound Pressures project is a realist review funded by the NIHR HSDR programme. The project aims to understand how multiple and intersecting pressures, such as
-
of agentic behaviour and publishing high-impact research. Candidates should possess a PhD (or be near completion) in PhD in Computer Science, AI, Security, or a related field. You will have a Strong background
-
these bioinformatic experiments. Access to a high-performance computer will be provided. The candidate must be capable of generating complex molecular compound models in silico and using current molecular dynamic
-
We are seeking a talented and motivated researcher to join the Mead Group to contribute to a major research programme focused on understanding and preventing disease progression in
-
strategic programme. Through multiomic and spatial biology exploration of temporally distinct samples from clinical trials and advanced biological models, an international consortium of leading colorectal
-
, other research assistants, psychology assistants, project and trial managers, and computer scientists. With a psychology degree (2:1 or above), you will have an interest in the psychological understanding
-
Raman’s cardiovascular research team. This role is embedded within a cutting-edge programme focused on integrating high-dimensional datasets, including advanced cardiac MRI (oxygen-sensitive, metabolic, and
-
About the role This is an exciting opportunity in the Department of Paediatrics, for a Research Assistant within Professor Simon Draper’s vaccine development programme, with a strong focus on